Cambridge Trust’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $180K | Buy |
455
+62
| +16% | +$24.5K | 0.01% | 275 |
|
|
2023
Q4 | $138K | Hold |
393
| – | – | 0.01% | 307 |
|
|
2023
Q3 | $147K | Sell |
393
-25
| -6% | -$9.38K | 0.01% | 298 |
|
|
2023
Q2 | $160K | Sell |
418
-259
| -38% | -$99.1K | 0.01% | 294 |
|
|
2023
Q1 | $235K | Sell |
677
-5,321
| -89% | -$1.84M | 0.01% | 260 |
|
|
2022
Q4 | $1.41M | Sell |
5,998
-1,072
| -15% | -$252K | 0.06% | 128 |
|
|
2022
Q3 | $1.74M | Sell |
7,070
-396
| -5% | -$97.5K | 0.08% | 115 |
|
|
2022
Q2 | $2.26M | Sell |
7,466
-797
| -10% | -$241K | 0.1% | 113 |
|
|
2022
Q1 | $3.39M | Buy |
8,263
+57
| +0.7% | +$23.4K | 0.12% | 109 |
|
|
2021
Q4 | $3.85M | Sell |
8,206
-3,852
| -32% | -$1.81M | 0.12% | 105 |
|
|
2021
Q3 | $5.12M | Sell |
12,058
-3,321
| -22% | -$1.41M | 0.19% | 91 |
|
|
2021
Q2 | $5.52M | Buy |
15,379
+179
| +1% | +$64.3K | 0.21% | 91 |
|
|
2021
Q1 | $4.28M | Sell |
15,200
-116
| -0.8% | -$32.7K | 0.17% | 94 |
|
|
2020
Q4 | $4.34M | Sell |
15,316
-3,635
| -19% | -$1.03M | 0.21% | 80 |
|
|
2020
Q3 | $5.21M | Sell |
18,951
-1,212
| -6% | -$333K | 0.27% | 73 |
|
|
2020
Q2 | $5.53M | Buy |
20,163
+869
| +5% | +$238K | 0.29% | 72 |
|
|
2020
Q1 | $2.94M | Buy |
19,294
+1,038
| +6% | +$158K | 0.2% | 80 |
|
|
2019
Q4 | $2.74M | Buy |
18,256
+669
| +4% | +$101K | 0.15% | 97 |
|
|
2019
Q3 | $2.49M | Buy |
17,587
+56
| +0.3% | +$7.94K | 0.14% | 92 |
|
|
2019
Q2 | $2.19M | Buy |
17,531
+1,859
| +12% | +$233K | 0.13% | 94 |
|
|
2019
Q1 | $1.73M | Buy |
15,672
+726
| +5% | +$80K | 0.1% | 105 |
|
|
2018
Q4 | $1.47M | Buy |
14,946
+1,308
| +10% | +$128K | 0.1% | 110 |
|
|
2018
Q3 | $1.68M | Buy |
13,638
+497
| +4% | +$61.4K | 0.1% | 103 |
|
|
2018
Q2 | $1.31M | Sell |
13,141
-149
| -1% | -$14.8K | 0.08% | 113 |
|
|
2018
Q1 | $1.17M | Buy |
13,290
+869
| +7% | +$76.8K | 0.07% | 124 |
|
|
2017
Q4 | $1.23M | Buy |
12,421
+817
| +7% | +$80.6K | 0.08% | 121 |
|
|
2017
Q3 | $1.12M | Sell |
11,604
-887
| -7% | -$85.4K | 0.07% | 121 |
|
|
2017
Q2 | $1.18M | Buy |
12,491
+745
| +6% | +$70.4K | 0.08% | 118 |
|
|
2017
Q1 | $958K | Buy |
11,746
+1,903
| +19% | +$155K | 0.06% | 138 |
|
|
2016
Q4 | $835K | Buy |
9,843
+989
| +11% | +$83.9K | 0.06% | 138 |
|
|
2016
Q3 | $659K | Buy |
8,854
+352
| +4% | +$26.2K | 0.05% | 152 |
|
|
2016
Q2 | $645K | Buy |
8,502
+249
| +3% | +$18.9K | 0.05% | 150 |
|
|
2016
Q1 | $572K | Buy |
8,253
+306
| +4% | +$21.2K | 0.05% | 143 |
|
|
2015
Q4 | $479K | Buy |
7,947
+704
| +10% | +$42.4K | 0.04% | 145 |
|
|
2015
Q3 | $392K | Sell |
7,243
-17
| -0.2% | -$920 | 0.03% | 158 |
|
|
2015
Q2 | $421K | Buy |
7,260
+256
| +4% | +$14.8K | 0.03% | 153 |
|
|
2015
Q1 | $421K | Buy |
7,004
+988
| +16% | +$59.4K | 0.04% | 150 |
|
|
2014
Q4 | $320K | Buy |
+6,016
| New | +$320K | 0.03% | 168 |
|